195 related articles for article (PubMed ID: 24471811)
1. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.
Ducray F; Demarquay G; Graus F; Decullier E; Antoine JC; Giometto B; Psimaras D; Delattre JY; Carpentier AF; Honnorat J
Eur J Neurol; 2014 May; 21(5):731-5. PubMed ID: 24471811
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.
Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz ML; Saiz A; Benyahia B; Dalmau J; Graus F
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1359-62. PubMed ID: 16801349
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
5. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Bataller L; Suárez-Calvet M; Saiz A; Dalmau J; Graus F
J Neuroimmunol; 2008 Sep; 201-202():163-5. PubMed ID: 18639938
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration.
Höftberger R; Kovacs GG; Sabater L; Nagy P; Racz G; Miquel R; Dalmau J; Graus F
J Neuroimmunol; 2013 Mar; 256(1-2):91-3. PubMed ID: 23273977
[TBL] [Abstract][Full Text] [Related]
8. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
12. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
14. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Höftberger R; Boronat A; Saiz A; Dalmau J; Graus F
PLoS One; 2013; 8(3):e60438. PubMed ID: 23536908
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
16. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
Finsterer J; Voigtländer T; Grisold W
J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies.
Hammack JE; Kimmel DW; O'Neill BP; Lennon VA
Mayo Clin Proc; 1990 Nov; 65(11):1423-31. PubMed ID: 2232897
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
[TBL] [Abstract][Full Text] [Related]
20. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung.
Bruylant K; Crols R; Humbel RL; Appel B; De Deyn PP
Clin Neurol Neurosurg; 2006 Jun; 108(4):415-7. PubMed ID: 16644410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
